Headache as a risk factor for dementia: A prospective population-based study

Cephalalgia

Volumn 34, Issue 5, 2014, Pages 327-335

  Hagen, Knut ^a,b   Stordal, Eystein ^a,c   Linde, Mattias ^a,b   Steiner, Timothy J ^a,d   Zwart, John Anker ^e   Stovner, Lars Jacob ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Namsos Hospital   (Norway)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Alzheimer's disease; headache; migraine; vascular dementia

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE; MULTIINFARCT DEMENTIA; POPULATION RESEARCH; PROSPECTIVE STUDY; RISK FACTOR;

ALZHEIMER'S DISEASE; HEADACHE; MIGRAINE; VASCULAR DEMENTIA;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DEMENTIA; FEMALE; HEADACHE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84898942928     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413513181     Document Type: Article

References (34)

1. Olesen J, Gustavsson A, Svensson M, et al. The economic cost of brain disorders in Europe. Eur J Neurol. 2012 ; 19: 155-162
2. Anstey KJ, Cherbuin N, Budge M, et al. Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies. Obes Rev. 2011 ; 12: e426 - e437
3. Xu W, Qiu C, Gatz M, et al. Mid- and late-life diabetes in relation to the risk of dementia: A population-based twin study. Diabetes. 2009 ; 58: 71-77
4. Sahathevan R, Brodtmann A, Donnan GA. Dementia, stroke, and vascular risk factors; a review. Int J Stroke. 2012 ; 7: 61-73
5. Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007 ; 27: 193-210
6. Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 2005 ; 330: 63-63
7. Scher AI, Terwindt GM, Picavet HS, et al. Cardiovascular risk factors and migraine: The GEM population-based study. Neurology. 2005 ; 64: 614-620
8. Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ. 2009 ; 339: b3914 - b3914
9. Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease. A population-based study. Neurology. 2010 ; 74: 628-635
10. Kruit MC, van Buchem MA, Launer LJ, et al. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA study. Cephalalgia. 2010 ; 30: 129-136
11. Gaist D, Pedersen L, Madsen C, et al. Long-term effects of migraine on cognitive function: A population-based study of Danish twins. Neurology. 2005 ; 64: 600-607
12. Kurth T, Mohamed S, Maillard P, et al. Headache, migraine, and structural brain lesions and function: Population based Epidemiology of Vascular Ageing-MRI study. BMJ. 2011 ; 342: c7357 - c7357
13. Baars MA, van Boxtel MP, Jolles J. Migraine does not affect cognitive decline: Results from the Maastricht aging study. Headache. 2010 ; 50: 176-184
14. Rist PM, Dufouil C, Glymour MM, et al. Migraine and cognitive decline in the population-based EVA study. Cephalalgia. 2011 ; 31: 1291-1300
15. Rist PM, Kang JH, Buring JE, et al. Migraine and cognitive decline among women: Prospective cohort study. BMJ. 2012 ; 345: e5027 - e5027
16. Winsvold BS, Hagen K, Aamodt AH, et al. Headache, migraine and cardiovascular risk factors. Eur J Neurology. 2011 ; 18: 504-511
17. Winsvold BS, Sandven I, Hagen K, et al. Migraine, headache and the development of metabolic syndrome: An 11-year follow-up in the Nord-Trøndelag Health Study (HUNT). Pain. 2013 ; 154: 1305-1311
18. Hagen K, Zwart JA, Vatten L, et al. Head-HUNT: Validity and reliability of a headache questionnaire in a large population-based study in Norway. Cephalalgia. 2000 ; 20: 244-251
19. Mykletun A, Stordal E, Dahl AA. The Hospital Anxiety and Depression (HAD) scale: Factor structure, item analyses, and internal consistency in a large population. Br J Psychiatry. 2001 ; 179: 540-544
20. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia. 1988 ; 8: 1-96
21. Hagen K, Zwart JA, Vatten L, et al. Prevalence of migraine and non-migrainous headache - Head-HUNT, a large population-based study. Cephalalgia. 2000 ; 20: 900-906
22. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: WHO, 1992, pp. 12 - 67. Available at: http://www.who.int/ classifications/icd/en/bluebook.pdf (accessed 12 November 2013).
23. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: WHO, 1993. Available at: http://www.who.int/classifications/icd/en/GRNBOOK.pdf (accessed 12 November 2013).
24. McKhann G, Drachmann D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under auspices of Department of Health and Human Services Task force on Alzheimer's Disease. Neurology. 1984 ; 34: 939-944
25. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop. Neurology. 1993 ; 43: 250-260
26. Bergh S, Holmen J, Saltvedt I, et al. Dementia and neuropsychiatric symptoms in nursing-home patients in Nord-Trøndelag County [in English and Norwegian]. Tidsskr Nor Laegeforen. 2012 ; 132: 1956-1959
27. Hagen K, Stovner LJ, Zwart JA. Potentials and pitfalls in analytical headache epidemiological studies. Lessons to be learned from the Head-HUNT Study. Cephalalgia. 2007 ; 27: 403-413
28. Morton R, Tyas S. Does a history of migraines increase the risk of Alzheimer's disease or vascular dementia?. Alzheimers Dement. 2012 ; 8: P504 - P504
29. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-analysis. BMJ. 2010 ; 341: c3666 - c3666
30. Silbert LC, Nelson C, Howieson DB, et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology. 2008 ; 71: 108-113
31. van Straaten EC, Harvey D, Scheltens P, et al. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol. 2008 ; 255: 1302-1308
32. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008 ; 4: 363-381
33. Stam AH, Weller CM, Janssens AC, et al. Migraine is not associated with enhanced atherosclerosis. Cephalalgia. 2013 ; 33: 228-235
34. Bigal ME, Kurth T, Hu H, et al. Migraine and cardiovascular disease. Possible mechanisms of interaction. Neurology. 2009 ; 72: 1864-1871